IRRITABLE BOWEL SYNDROME (IBS) - INFLAMMATORY BOWEL DISEASE (IBD)

IRRITABLE BOWEL SYNDROME (IBS) - INFLAMMATORY BOWEL DISEASE (IBD): 

Also See: Bowel Disorders

• Cannabis and Stomach Pain: https://realmofcaring.org/cannabis-and-stomach-pain/?utm_source=Klaviyo&utm_medium=campaign&utm_campaign=08%2F08%20Cannabis%20and%20Stomach%20Pain&_kx=pQ9r0zLSMIUHWYqd0TqbvxV_DAPx16hhlJ43MlrVzik.UvV543
• 2023
• Medical cannabis increases appetite but not body weight in patients with Inflammatory Bowel Disease (IBD). https://www.mdpi.com/2072-6643/16/1/78 
• Proof of Concept: Open label trial of CBD/CBG oral tincture in the management of Symptoms in adult patients with Irritable Bowel Syndrome. https://journals.lww.com/ajg/fulltext/2023/10001/s648_proof_of_concept_open_label_trial_of_cbd_cbg.1004 
• Management of Chronic Anal Fissure with a Novel Topical Hemp-Herbal-Based Ointment: A Pilot Study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940646/
• A survey of cannabis use among patients with Inflammatory Bowel Disease (IBD). https://www.mdpi.com/1660-4601/20/6/5129 
• 2022:
• Impact of Cannabis use on Inpatient inflammatory bowel disease outcomes in 2 states legalizing recreational cannabis. https://academic.oup.com/crohnscolitis360/article/4/2/otac015/6576191?login=false  
• Cannabinoid therapeutic effects in inflammatory bowel diseases: A systematic review and meta-analysis of randomized controlled trials. https://www.cannabisclinicians.org/wp-content/uploads/2022/10/Cannabinoid-Therapeutic-Effects-in-Inflammatory-Bowel-Diseases_-A-Systematic-Review-and-Meta-Analysis-of-Randomized-Controlled-Trials.pdf 
• The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry. (2022)https://www.tandfonline.com/doi/full/10.1080/17474124.2022.2161046 
• The cannabinoids and terpenes with anti-inflammatory potential: https://cannabishealthnews.co.uk/2022/11/22/cannabinoids-and-terpenes-anti-inflammatory-potential/
• 2020:
• Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment: https://www.frontiersin.org/articles/10.3389/fnins.2020.00371/full
• Endocannabinoid System in Irritable Bowel Syndrome and Cannabis as a therapy:  https://www.sciencedirect.com/science/article/abs/pii/S0965229919310179?via%3Dihub
• Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. (Austria/ Germany, abstract, 2020) https://pubmed.ncbi.nlm.nih.gov/31899693/ 
• 2019
• Cannabis Oil Use by Adolescents and Young Adults With Inflammatory Bowel Disease. (USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/30801394/ 
• Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects. (Israel, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31567639/ 
• Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis. (Canada/ USA, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/30807448/ 
• Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases. (USA, abstract, 2019) https://link.springer.com/article/10.1007/s11894-019-0670-0 
• Use of Medical Cannabis in Patients With Inflammatory Bowel Disease. (USA, interview, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366240/ 
• Activation of cannabinoid 2 receptor relieves colonic hypermotility in a rat model of irritable bowel syndrome. (China, full, 2019) https://onlinelibrary.wiley.com/doi/full/10.1111/nmo.13555 
• The Important Role of the Endocannabinoid System and the Endocannabinoidome in Gut Health. (Greece, full, 2019) https://trugen3.com/the-important-role-of-the-endocannabinoid-system-and-the-endocannabinoidome-in-gut-health/ 
• Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis. (Poland/ Germany, full, 2019) https://www.jgld.ro/jgld/index.php/jgld/article/view/265/167 
• Insights into the role of cannabis in the management of inflammatory bowel disease. (Canada, full, 2019) https://journals.sagepub.com/doi/full/10.1177/1756284819870977 
• Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer. (Austria/ Germany, full, 2019) https://www.nature.com/articles/s41598-019-38865-4 
• Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease? (Israel, full, 2019) https://link.springer.com/article/10.1007%2Fs10620-019-05763-8 
• Use of Medical Cannabis in Patients With Inflammatory Bowel Disease (interview–2019)
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366240/
• The Endocannabinoid System and Clinical Endocannabinoid Deficiency. (news – 2019)
  https://cannabisaficionado.com/clinical-endocannabinoid-deficiency/
• 2018
• Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease. (USA, abstract, 2018) https://link.springer.com/article/10.1007%2Fs10620-018-5040-5 
• Endocannabinoids in the treatment of gastrointestinal inflammation and symptoms. (UK/ Italy, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S1471489218300183?via%3Dihub 
• Cannabinoid pharmacology and therapy in gut disorders. (Spain, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303186 
• The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn’s and Colitis Foundation. (USA, full, 2018) https://academic.oup.com/ibdjournal/article/25/3/427/5144402?login=true  
• Marijuana Use by Adolescents and Young Adults with Inflammatory Bowel Disease. (USA, full, 2018) https://www.jpeds.com/article/S0022-3476(18)30388-3/fulltext 
• Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis. (USA/ UK, full, 2018) https://www.jci.org/articles/view/96817 
• Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation. (Austria, full, 2018) https://link.springer.com/article/10.1007%2Fs00418-018-1719-0 
• The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111500/ 
• Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease. (USA, full, 2018) https://academic.oup.com/ibdjournal/article/24/11/2309/4999337
• 2017
• Potential of plant-sourced phenols for inflammatory bowel disease. (China, abstract, 2017) https://pubmed.ncbi.nlm.nih.gov/28990509/ 
• G protein-coupled receptor 55 (GPR55) expresses differently in patients with Crohn's disease and ulcerative colitis. (Poland, abstract, 2017) https://www.tandfonline.com/doi/abs/10.1080/00365521.2017.1298834?journalCode=igas20 
• Role of cannabis in digestive disorders. (USA/ India, abstract, 2017) https://www.semanticscholar.org/paper/Role-of-cannabis-in-digestive-disorders-Goyal-Singla/232a2b4bf1a1211f32a299f735c94c5e6a272b44 
• The development of functional gastrointestinal diseases: Genetic aspects. (Russia, abstract, 2017) https://pubmed.ncbi.nlm.nih.gov/28635880/ 
• The role of CB1 in intestinal permeability and inflammation. (UK/ Ireland, PDF, 2017) https://www.researchgate.net/publication/316111984_The_role_of_CB1_in_intestinal_permeability_and_inflammation  
• Endocannabinoid-related compounds in gastrointestinal diseases. (Italy/ UK, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783846/ 
• Pharmacogenetics and the treatment of functional gastrointestinal disorders. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591464/ 
• Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid system protects against colitis and ameliorates remote organ lesions in mice. (China, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740744/ 
• Anti-Inflammatory Activity in Colon Models Is Derived from Δ9- Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts. (Israel, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627671/ 
• Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go? (Germany/ Austria, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/ 
• Scientists Attempt to Treat IBS with Cannabis Chewing Gum (news–2017) https://www.marijuanatimes.org/scientists-attempt-to-treat-ibs-with-cannabis-chewing-gum/
• 2016
• Medical Cannabis - another piece in the mosaic of autoimmunity? (Israel, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27859024/ 
• Cannabinoids and GI Disorders: Endogenous and Exogenous. (USA, abstract, 2016) https://link.springer.com/article/10.1007/s11938-016-0111-1 
• Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. (Germany, abstract, 2016) https://link.springer.com/article/10.1007%2Fs00482-015-0087-0 
• Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis. (USA, PDF, 2016) https://www.researchgate.net/publication/283729505_Dietary_Supplement_Therapies_for_Inflammatory_Bowel_Disease_Crohn's_Disease_and_Ulcerative_Colitis 
• Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885506/ 
• The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease. (Austria/ Germany, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130148/ 
• Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High. (USA, full,  2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250561/ 
• RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives. (Poland/ Germany/ USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916644/ 
• The role of the endocannabinoid system in the brain-gut axis. (Canada/ USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/ 
• The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. (Iran, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056566/ 
• Therapeutic Use of Cannabis in Inflammatory Bowel Disease. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193087/ 
• Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK. (China, full, 2016) https://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm  
• The CB2 receptor and its role as a regulator of inflammation. (Canada, full, 2016) https://link.springer.com/article/10.1007/s00018-016-2300-4 
• Endocannabinoids in the Gut. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940133/ 
• Cannabis as a Treatment for Inflammatory Bowel Disease (news–2016) https://www.marijuanatimes.org/cannabis-as-a-treatment-for-inflammatory-bowel-disease/
• 2015
• Cannabis Superior To Drugs For Inflammatory Bowel Condition (Crohn’s Disease) (news–2015) http://www.greenmedinfo.com/blog/cannabis-superior-drugs-inflammatory-bowel-condition-crohns-disease
• Many Teens With Chronic Illnesses Use Alcohol, Pot (news–2015) http://www.medicinenet.com/script/main/art.asp?articlekey=190363
• 2014
• L. Acidophilus and the CB2 Receptor (news–2014) https://www.sclabs.com/l-acidophilus-and-the-cb2-receptor/
• 2013
• Still Believe Nature Got It Wrong? Top 10 Health Benefits of Marijuana (news-2013) http://www.wakingtimes.com/2013/05/01/still-believe-nature-got-it-wrong-top-10-health-benefits-of-marijuana/
• 2011
• Cannabis Use Common Among Patients With Inflammatory Bowel Disease, Study Says (news–2011) http://norml.org/news/2011/08/04/cannabis-use-common-among-patients-with-inflammatory-boweldisease-study-says